reviewTop 1% cited
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
European Urology · 2008 · Vol. 54(2) · pp. 303–314
Marko Babjuk✉(Charles University)Willem Oosterlinck(Ghent University Hospital)Richard Sylvester(European Organisation for Research and Treatment of Cancer)Eero Kaasinen(Hyvinkää Hospital)Andreas BöhleJ. Palou-Redorta(Universitat Autònoma de Barcelona)
Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesInfectious Disease Case Reports and TreatmentsMedicineCystectomyBladder cancerCystoscopyChemotherapyUrologyCarcinoma in situCarcinomaTumor progressionCancer
MeSH terms
Administration, IntravesicalUrinary Bladder NeoplasmsCarcinoma, Transitional CellHumansNeoplasm InvasivenessChemotherapy, Adjuvant
Citations
745
FWCI
96.91
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
Cited by
The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
European Urology · 2009 · 640 citations
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
European Urology · 2009 · 749 citations
References
Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression
Urology · 2004 · 458 citations
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
European Urology · 2006 · 2,943 citations
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
The Journal of Urology · 2002 · 1,296 citations
Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies
European Urology · 2002 · 678 citations
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Urology · 2005 · 427 citations
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
The Journal of Urology · 2000 · 1,298 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.